Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1027785-15-4

Post Buying Request

1027785-15-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1027785-15-4 Usage

Structure

Heterocyclic carboxylic acid with a pyridine ring fused to a pyrrole ring, and a cyclopropyl group attached to the carbon atom at position 2 of the pyridine ring

Pharmaceutical applications

Ability to modulate certain biological pathways, making it of interest in drug discovery and development

Organic synthesis

Used as a building block for the construction of more complex molecules

Ongoing research

Efforts to explore its biological activities and potential therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 1027785-15-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,7,7,8 and 5 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1027785-15:
(9*1)+(8*0)+(7*2)+(6*7)+(5*7)+(4*8)+(3*5)+(2*1)+(1*5)=154
154 % 10 = 4
So 1027785-15-4 is a valid CAS Registry Number.

1027785-15-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Cyclopropyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1027785-15-4 SDS

1027785-15-4Upstream product

1027785-15-4Downstream Products

1027785-15-4Relevant articles and documents

NOVEL KINASE INHIBITORS

-

Page/Page column 34, (2008/12/05)

The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts thereof. The Formula (I) compounds inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1 and IGFR-1, thereby making them usefu

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1027785-15-4